ÃâÒßѧÊÔÌâ
073(xAkL{ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
r
(uM$R$o 1. Fas(CD95)/FasL
B$bsh. 2. common chain of cytokine receptor
MiC&av 3 . TCR/CD3 complex
$H#&.IjY 4. negaive selection of thymocytes
cZu:dwE 5. artificial active immune
m[}$&i$( 6. anti-idiotypic
J=$v+8&. 7. IgSF
C>+U
Z 8. Integrin
C.@zVt 9. chemokine
yaf2+zV* 10. B7/CD28
OD i)# ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
DGU$3w 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
/'I/sWEV 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
^I0SfZ'Y 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
K|B1jdzL 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
{5to;\.
PXkPC%j 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
`mMD e µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
M6e"4Gh Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
TqlUe@E 1. B7/CD28
}{lOsZA 2. Th1 subset
aA:Ky&5e 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
=Xp3UNXg 4. antibody affinity maturation
i{`>!)U 5. AP-1
TWn7&,N 6. single chain variable fragment£¨ScFv£©
^|8cS0dK]Q 7. NK cell receptor
`Q{k
iy 8. Zinkernagel-Doherty phenomenon
6s Pd")%G 9. Ig fold
[iDa6mcth 10. CD40/CD40L
>V]>h&` ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
%o?fE4o' 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
(Q@m;i> 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
7Fq|Zc`P 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
a#kZY7s Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
ztTpMj 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
]AN)M> 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
LIR2
B"3F 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
H(0d(c1s Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
-5Ccuk>6 £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
g'mkhF( Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
ftK.jj1: 1.Co-stimulators (or co-stimulating molecules)
p1 o?^A& 2.NK-kB
@]cpPW-b 3.Immunoglobulin superfamily
!1!uB } 4.antigen-presenting cell (APC)
BG'gk#J+f 5.death domain
E P<U:F 6.CCR and CXCR
\f+R! 7.Lectin (or mitogen)
0|HhA,u 8.Clusters of differentiation, CD)
#M_
QSD}& 9.B7 family
atPf527\` 10.Cytotoxic T lymphocyte, CTL)
(=p}b:Z 11.IL-15 and IL-15 receptor (IL-15R)
{8t;nsdm! 12.MHC restriction
E
fqa*,k 13.Affinity-chromatography
!FO92 P16 14.Cyctosprin A, CsA
(2%C%#]8 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
U:`rNHl ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
( /uL6W d0 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
8y+Gvk: 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
oE5+ 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
S-v9z:M3 Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
8_KXli}7= ÃâÒßѧרҵ£º
tl#hCy 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
LxMOs Nv Ïû»¯ÄÚ¿Æ£º
!N!M
NsyDz 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
+L_.XToq- ѪҺ²¡Ñ§×¨Òµ£º
qHvW{0E 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
!lHsJ)t Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
Z5NuLB' (רҵ»ù´¡: ÃâÒßѧ)
u} KiSZxt Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
c5U1N&k5& 1. ADCC(antibody dependent cell-mediated cytotoxicity)
2b !b
- 2. »·æß¾úËØ(cyclosporin)
_&yQW&vH# 3. KIR(killer cell inhibitory receptor)
k"AY7vq@!P 4. HLDA(human leucocyte differentiation antigen)
1)k))w 9 5. Interleukin 18(IL-18)
p|W:;( 6. ÕûºÏËØ(integrin)
wus] 7. Fas/FasL
6g$+ ))g 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
{!x-kF_ 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
:<nL9y jt 10. Th1/Th2
p%j@2U 11. »ùÒòÒßÃç(DNAÒßÃç)
tMupX-V 12. chemokines and chemokine receptor
vn|X,1o 13. ÃâÒßÄÍÊÜ
1OJ:Vy}n 14. ¹²´Ì¼¤·Ö×Ó
*6k
(xL 15. ËÀÍö½á¹¹Óò(death domain)
Kz 'W
| ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
l1YyZ ^Z 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
t$s)S> 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
@ /c{gD £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
p61"a,Xc £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
W6]iJ £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
MJ>(HJY6?% £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
A7ck-9dT/L 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
~*G I<n Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
hydn" 9; ÎÊ´ðÌâ(ÿÌâ25·Ö)
e3',? 5j 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
arDY@o~ 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
o$2f
ML 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
OhIUm4
=|$ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£